International Journal of Cancer Management

Published by: Kowsar

A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum

Afshin Fathi 1 , Firuz Amani 2 , Mohammad Davoodi 3 , Sara Bahadoram 4 and Mohammad Bahadoram 5 , *
Authors Information
1 Associate Professor of Pediatric Haematology Oncology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Associate Professor of Biostatistics and Epidemiology, Ardabil University of Medical Sciences, Ardabil, IR Iran
3 Department of Radiology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Pediatrics, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IR Iran
5 Medical Student Research Committee & Social Determinant of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 2016, 9 (4); e4277
  • Published Online: June 15, 2016
  • Article Type: Case Report
  • Received: October 12, 2015
  • Revised: February 22, 2016
  • Accepted: May 30, 2016
  • DOI: 10.17795/ijcp-4277

To Cite: Fathi A, Amani F, Davoodi M, Bahadoram S, Bahadoram M. A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum, Int J Cancer Manag. 2016 ; 9(4):e4277. doi: 10.17795/ijcp-4277.

Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, et al. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol). 2013; 25(3): 171-7[DOI][PubMed]
  • 2. Cesmebasi A, Gabriel A, Niku D, Bukala K, Donnelly J, Fields PJ, et al. Pediatric head and neck tumors: an intra-demographic analysis using the SEER* database. Med Sci Monit. 2014; 20: 2536-42[DOI][PubMed]
  • 3. Wang Y, Zhang Y, Ma S. Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol. 2013; 37(6): 793-802[DOI][PubMed]
  • 4. Al-Azri A, Al-Sheibani S. Nasopharyngeal Carcinoma in Oman: A Descriptive Analysis. Oman Med J. 2015; 30(3): 167-72[DOI][PubMed]
  • 5. Wong TS, Kwong DL, Sham JS, Wei WI, Kwong YL, Yuen AP. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res. 2004; 10(7): 2401-6[PubMed]
  • 6. Liu W, Tang Y, Gao L, Huang X, Luo J, Zhang S, et al. Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients. Radiat Oncol. 2014; 9: 274[DOI][PubMed]
  • 7. Guruprasad B, Tanvir P, Rohan B, Kavitha S, Naik SM, Appaji L. Paediatric nasopharyngeal carcinoma: an 8-year study from a tertiary care cancer centre in South India. Indian J Otolaryngol Head Neck Surg. 2013; 65: 131-4[DOI][PubMed]
  • 8. Du XJ, Tang LL, Chen L, Mao YP, Guo R, Liu X, et al. Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy. Sci Rep. 2015; 5: 16664[DOI][PubMed]
  • 9. Zhang JW, Qin T, Hong SD, Zhang J, Fang WF, Zhao YY, et al. Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma. Chin J Cancer. 2015; 34(4): 177-83[DOI][PubMed]
  • 10. Paiar F, Di Cataldo V, Zei G, Pasquetti EM, Cecchini S, Meattini I, et al. Role of chemotherapy in nasopharyngeal carcinoma. Oncol Rev. 2012; 6(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments